·
11 Min Read

Naloxone: FDA approves over-the-counter Narcan nasal spray with Bobby Mukkamala, MD

The AMA Update covers a range of health care topics affecting the lives of physicians and patients. Learn more about Narcan, the over-the-counter naloxone nasal spray, and more.

series
Behavioral Health
AMA Update
·
11 Min Read

Naloxone: FDA approves over-the-counter Narcan nasal spray with Bobby Mukkamala, MD [Podcast]

The AMA Update covers a range of health care topics affecting the lives of physicians and patients. Learn more about Narcan, the over-the-counter naloxone nasal spray, and more.

series
Behavioral Health
AMA Update Podcast
·
5 Min Read

Top news stories from AMA Morning Rounds®: Week of April 10, 2023

In the news: “Hacktivist” threat in health care, autism rates among girls, xylazine in fentanyl, mifepristone decision sets a dangerous precedent and more.

Publications & Newsletters
Katherine Pannel, DO
·
6 Min Read

How this DO’s advocacy will help prevent drug-overdose deaths

AMA member Katherine Pannel, DO, helped persuade lawmakers to decriminalize fentanyl test strips in Mississippi. Learn more.

Behavioral Health
·
3 Min Read

AMA launches resource to help physicians meet DEA training requirement

The AMA Ed Hub™ has a new educational webpage for physicians to complete required training on treating patients with opioid or other substance use disorders.

Press Releases
·
4 Min Read

Top news stories from AMA Morning Rounds®: Week of March 27, 2023

In the news: FDA rule on salt substitutes, undiagnosed atrial fibrillation in the U.S., Narcan (naloxone) to be available over the counter and more.

Publications & Newsletters
Rahul Gupta, MD, speaking at the 2023 National Advocacy Conference
·
5 Min Read

Every 5 minutes a person dies of drug overdose. This must end.

Rahul Gupta, MD, MPH, is the first physician to direct the White House’s drug-control policy. Learn why he says treatment is key to the strategy.

Behavioral Health
·
2 Min Read

AMA statement on making naloxone available over the counter

The AMA strongly supports the FDA decision to make the opioid overdose-reversing drug naloxone available over the counter, a position we have long championed.

Press Releases
·
4 Min Read

Top news stories from AMA Morning Rounds®: Week of March 20, 2023

In the news: Alarming spread of deadly and drug-resistant Candida auris fungus, growing drug shortages, autism spectrum disorder on the rise and more.

Publications & Newsletters